Amy Kruse

Amy Kruse is chief investment officer of Satori Neuro, where she invests in mental health, neurotechnology, and human performance. She holds a PhD in neuroscience from the University of Illinois Urbana-Champaign and was a programme manager at DARPA, where she created the agency's first performance-oriented neuroscience programmes. She was previously a general partner at Prime Movers Lab, where she joined the board of Paradromics, and chief scientific officer at Optios.